source
- Evommune pays $30 million to Hinova for rights to develop oral VAV1 molecular glue degrader EVO570 outside ChinaEvommune announced a licensing agreement with Chinese firm Hinova Pharmaceuticals, paying $30 million upfront for access to a preclinical molecular glue program. The agreement gives Evommune the r…
- MIT defamation verdict awards $6 million to former star scientist, sparking campus debate over harassment claimsA Boston jury awarded former MIT biologist David Sabatini $6 million in a defamation case against former colleague Kristin Knouse, a biology professor at the institute. The judgment stems from a la…